IMPROVE-IT clinical implications. Should the "high-intensity cholesterol-lowering therapy" strategy replace the "high-intensity statin therapy"?
作者信息
Masana Luis, Pedro-Botet Juan, Civeira Fernando
机构信息
Vascular Medicine and Metabolism Unit, Research Unit on Lipids and Atherosclerosis, "Sant Joan" University Hospital, Universitat Rovira i Virgili, IISPV, Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), Reus, Spain.
Lipid and Vascular Risk Unit, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain.
出版信息
Atherosclerosis. 2015 May;240(1):161-2. doi: 10.1016/j.atherosclerosis.2015.03.002. Epub 2015 Mar 10.
Abstract
摘要
Zotero 插件